A Bullish Chart Speaks for Itself

It is appropriately stated that a picture is more than 1000 words as when one gets adept in stock market the charts start speaking for itself. One such chart which shows that the stock is in bullish territory is Sun Pharma. Have a look at below screenshot of the chart and one will realise that the growth prospects of stock is just tremendous.


We are bullish on the long term prospects of  SunPharma but are susceptible about the performance of Taro which may not show a similar performance in the next quarter
Sun Pharma is going to perform better going forward mainly driven by:

• Resumption of sales from the US based subsidiary Caraco Pharma post USFDA clearance.
• Contribution from newly acquired Dusa Pharma and URL Pharma in US.
• Launch of key products in US and emerging markets including India.
• Sun Pharma is expected to show 21 per cent and 16 per cent revenue and PAT CAGR respectively over FY2012-15E.

Verdict
With a strong cash balance, Sun Pharma is well positioned to capitalise on the growth opportunities. Its debt-free balance sheet insulates it from the negative impact of volatile currency. Thus it makes sense to add this stock as a long term investment to finance your kids future and not to forget our hot stock of the day for your intraday needs. Do remember to check the top 10 stocks for your investment needs.